New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
07:03 EDTINSYInsys Therapeutics completes human abuse study for Dronabinol Oral Solution
Insys Therapeutics announced the successful completion of a human abuse study for Dronabinol Oral Solution, its proprietary, orally administered liquid formulation of the synthetic cannabinoid dronabinol in development for the treatment of chemotherapy induced nausea and vomiting, or CINV, and anorexia associated with weight loss in patients with AIDS.
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
07:20 EDTINSYInsys Therapeutics cannabidiol receives fast track designation From FDA
Subscribe for More Information
February 24, 2015
07:07 EDTINSYInsys Therapeutics in-licenses novel mast cell therapy for chronic pelvic pain
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use